Alnylam Pharmaceuticals reported $433.8M in Loan Capital for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Agios Pharmaceuticals AGIO:US $ 0M 0.17M
Alexion Pharmaceuticals ALXN:US $ 2388.8M 30.8M
Alnylam Pharmaceuticals ALNY:US $ 433.8M 0.65M
Amgen AMGN:US $ 33291M 4833M
Arena Pharmaceuticals ARNA:US $ 37.48M 1.3M
Arrowhead Research ARWR:US $ 0 0
Avrobio Inc AVRO:US $ 0 0
Biomarin Pharmaceutical BMRN:US $ 1078.09M 0.98M
Bluebird Bio BLUE:US $ 0M 0M
Dicerna Pharmaceuticals DRNA:US $ 0M 0M
Gw Pharmaceuticals GWPH:US $ 14.16M 0.14M
IONIS PHARMACEUT IONS:US $ 1303M 62.3M
Mirati Therapeutics MRTX:US $ 0M 0M
Moderna Inc MRNA:US $ 238M 90M
Neurocrine Biosciences NBIX:US $ 330.7M 4.4M
Novartis NVS:US $ 24715M 1776M
Ptc Therapeutics PTCT:US $ 972.21M 143.17M
Regeneron Pharmaceuticals REGN:US $ 1979.6M 0.4M
Sangamo Biosciences SGMO:US $ 0M 0M
Sarepta Therapeutics SRPT:US $ 1094.91M 1.93M
Takeda 4502:JP Y 4016473M 365116M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
Vertex Pharmaceuticals VRTX:US $ 513.26M 11.67M
Xencor XNCR:US $ 0M 0M
YTE INCY:US $ 31.38M 0.46M